APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prostaglandin E2 Receptor EP4 Subtype

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Prostaglandin E2 Receptor EP4 Subtype Market Analysis and Forecast 2026-2032

19 December 2025199 pages

Choose your research edition.

Industry ResearchProstaglandin E2 Receptor EP4 Subtype Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Prostaglandin E2 Receptor EP4 Subtype Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Prostaglandin E2 Receptor EP4 Subtype Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prostaglandin E2 Receptor EP4 Subtype Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Prostaglandin E2 Receptor EP4 Subtype Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Prostaglandin E2 Receptor EP4 Subtype market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Prostaglandin E2 Receptor EP4 Subtype is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Prostaglandin E2 Receptor EP4 Subtype is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Prostaglandin E2 Receptor EP4 Subtype is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Prostaglandin E2 Receptor EP4 Subtype is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Prostaglandin E2 Receptor EP4 Subtype include Eisai Co Ltd, Eli Lilly and Co, Rottapharm Biotech Srl, RaQualia Pharma Inc, Ono Pharmaceutical Co Ltd and Kaken Pharmaceutical Co Ltd, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Prostaglandin E2 Receptor EP4 Subtype, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Prostaglandin E2 Receptor EP4 Subtype, also provides the revenue of main regions and countries. Of the upcoming market potential for Prostaglandin E2 Receptor EP4 Subtype, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Prostaglandin E2 Receptor EP4 Subtype revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Prostaglandin E2 Receptor EP4 Subtype market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Prostaglandin E2 Receptor EP4 Subtype revenue, projected growth trends, production technology, application and end-user industry.

Prostaglandin E2 Receptor EP4 Subtype Segment by Company

Eisai Co Ltd

Eli Lilly and Co

Rottapharm Biotech Srl

RaQualia Pharma Inc

Ono Pharmaceutical Co Ltd

Kaken Pharmaceutical Co Ltd

Prostaglandin E2 Receptor EP4 Subtype Segment by Type

ONO-4232

KAG-308

ER-886046

Grapiprant

E-7046

Others

Prostaglandin E2 Receptor EP4 Subtype Segment by Application

Breast Cancer

Chronic Pain

Acute Pain

Allergies

Lung Cancer

Others

Prostaglandin E2 Receptor EP4 Subtype Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prostaglandin E2 Receptor EP4 Subtype market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prostaglandin E2 Receptor EP4 Subtype and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prostaglandin E2 Receptor EP4 Subtype.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Prostaglandin E2 Receptor EP4 Subtype in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Prostaglandin E2 Receptor EP4 Subtype company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prostaglandin E2 Receptor EP4 Subtype revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Prostaglandin E2 Receptor EP4 Subtype Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. ONO-4232 Major Player Table 3. KAG-308 Major Player Table 4. ER-886046 Major Player Table 5. Grapiprant Major Player Table 6. E-7046 Major Player Table 7. Others Major Player Table 8. Global Prostaglandin E2 Receptor EP4 Subtype Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Breast Cancer Major Player Table 10. Chronic Pain Major Player Table 11. Acute Pain Major Player Table 12. Allergies Major Player Table 13. Lung Cancer Major Player Table 14. Others Major Player Table 15. Prostaglandin E2 Receptor EP4 Subtype Industry Trends Table 16. Prostaglandin E2 Receptor EP4 Subtype Industry Drivers Table 17. Prostaglandin E2 Receptor EP4 Subtype Industry Opportunities and Challenges Table 18. Prostaglandin E2 Receptor EP4 Subtype Industry Restraints Table 19. Global Prostaglandin E2 Receptor EP4 Subtype Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 20. Global Prostaglandin E2 Receptor EP4 Subtype Market Size by Region (2021-2026) & (US$ Million) Table 21. Global Prostaglandin E2 Receptor EP4 Subtype Market Share by Region (2021-2026) Table 22. Global Prostaglandin E2 Receptor EP4 Subtype Market Size by Region (2027-2032) & (US$ Million) Table 23. Global Prostaglandin E2 Receptor EP4 Subtype Market Share by Region (2027-2032) Table 24. Global Prostaglandin E2 Receptor EP4 Subtype Revenue by Players (US$ Million) & (2021-2026) Table 25. Global Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Players (2021-2026) Table 26. Global Prostaglandin E2 Receptor EP4 Subtype Key Players Ranking, 2024 VS 2025 VS 2026 Table 27. Global Prostaglandin E2 Receptor EP4 Subtype Key Players Headquarters & Area Served Table 28. Global Prostaglandin E2 Receptor EP4 Subtype Players, Product Type & Application Table 29. Global Prostaglandin E2 Receptor EP4 Subtype Players Establishment Date Table 30. Global Players Market Concentration Ratio (CR5 and HHI) Table 31. Global Prostaglandin E2 Receptor EP4 Subtype by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Prostaglandin E2 Receptor EP4 Subtype Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Type (2021-2026) Table 36. Global Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Type (2027-2032) Table 37. Global Prostaglandin E2 Receptor EP4 Subtype Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2021-2026) & (US$ Million) Table 39. Global Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2027-2032) & (US$ Million) Table 40. Global Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Application (2021-2026) Table 41. Global Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Application (2027-2032) Table 42. Eisai Co Ltd Company Information Table 43. Eisai Co Ltd Business Overview Table 44. Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Product Portfolio Table 46. Eisai Co Ltd Recent Development Table 47. Eli Lilly and Co Company Information Table 48. Eli Lilly and Co Business Overview Table 49. Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype Product Portfolio Table 51. Eli Lilly and Co Recent Development Table 52. Rottapharm Biotech Srl Company Information Table 53. Rottapharm Biotech Srl Business Overview Table 54. Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype Product Portfolio Table 56. Rottapharm Biotech Srl Recent Development Table 57. RaQualia Pharma Inc Company Information Table 58. RaQualia Pharma Inc Business Overview Table 59. RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype Product Portfolio Table 61. RaQualia Pharma Inc Recent Development Table 62. Ono Pharmaceutical Co Ltd Company Information Table 63. Ono Pharmaceutical Co Ltd Business Overview Table 64. Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Product Portfolio Table 66. Ono Pharmaceutical Co Ltd Recent Development Table 67. Kaken Pharmaceutical Co Ltd Company Information Table 68. Kaken Pharmaceutical Co Ltd Business Overview Table 69. Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Product Portfolio Table 71. Kaken Pharmaceutical Co Ltd Recent Development Table 72. North America Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2021-2026) & (US$ Million) Table 73. North America Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2027-2032) & (US$ Million) Table 74. North America Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2021-2026) & (US$ Million) Table 75. North America Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2027-2032) & (US$ Million) Table 76. North America Prostaglandin E2 Receptor EP4 Subtype Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 77. North America Prostaglandin E2 Receptor EP4 Subtype Revenue by Country (2021-2026) & (US$ Million) Table 78. North America Prostaglandin E2 Receptor EP4 Subtype Revenue by Country (US$ Million) & (2027-2032) Table 79. Europe Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2021-2026) & (US$ Million) Table 80. Europe Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2027-2032) & (US$ Million) Table 81. Europe Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2021-2026) & (US$ Million) Table 82. Europe Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2027-2032) & (US$ Million) Table 83. Europe Prostaglandin E2 Receptor EP4 Subtype Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 84. Europe Prostaglandin E2 Receptor EP4 Subtype Revenue by Country (2021-2026) & (US$ Million) Table 85. Europe Prostaglandin E2 Receptor EP4 Subtype Revenue by Country (US$ Million) & (2027-2032) Table 86. China Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2021-2026) & (US$ Million) Table 87. China Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2027-2032) & (US$ Million) Table 88. China Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2021-2026) & (US$ Million) Table 89. China Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2027-2032) & (US$ Million) Table 90. Asia Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2021-2026) & (US$ Million) Table 91. Asia Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2027-2032) & (US$ Million) Table 92. Asia Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2021-2026) & (US$ Million) Table 93. Asia Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2027-2032) & (US$ Million) Table 94. Asia Prostaglandin E2 Receptor EP4 Subtype Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 95. Asia Prostaglandin E2 Receptor EP4 Subtype Revenue by Region (US$ Million) & (2021-2026) Table 96. Asia Prostaglandin E2 Receptor EP4 Subtype Revenue by Region (US$ Million) & (2027-2032) Table 97. SAMEA Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2021-2026) & (US$ Million) Table 98. SAMEA Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2027-2032) & (US$ Million) Table 99. SAMEA Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2021-2026) & (US$ Million) Table 100. SAMEA Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2027-2032) & (US$ Million) Table 101. SAMEA Prostaglandin E2 Receptor EP4 Subtype Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. SAMEA Prostaglandin E2 Receptor EP4 Subtype Revenue by Country (2021-2026) & (US$ Million) Table 103. SAMEA Prostaglandin E2 Receptor EP4 Subtype Revenue by Country (US$ Million) & (2027-2032) Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. Prostaglandin E2 Receptor EP4 Subtype Image Figure 2. Global Prostaglandin E2 Receptor EP4 Subtype Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prostaglandin E2 Receptor EP4 Subtype Market Size Share 2021 VS 2025 VS 2032 Figure 4. ONO-4232 Image Figure 5. KAG-308 Image Figure 6. ER-886046 Image Figure 7. Grapiprant Image Figure 8. E-7046 Image Figure 9. Others Image Figure 10. Global Prostaglandin E2 Receptor EP4 Subtype Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Prostaglandin E2 Receptor EP4 Subtype Market Size Share 2021 VS 2025 VS 2032 Figure 12. Breast Cancer Image Figure 13. Chronic Pain Image Figure 14. Acute Pain Image Figure 15. Allergies Image Figure 16. Lung Cancer Image Figure 17. Others Image Figure 18. Global Prostaglandin E2 Receptor EP4 Subtype Market Size (US$ Million) & (2021-2032) Figure 19. Global Prostaglandin E2 Receptor EP4 Subtype Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 20. Global Prostaglandin E2 Receptor EP4 Subtype Market Share by Region: 2021 VS 2025 VS 2032 Figure 21. Global Prostaglandin E2 Receptor EP4 Subtype Players Revenue Share Top 10 and Top 5 in 2025 Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Type (2021-2032) Figure 26. Global Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 28. Global Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Application (2021-2032) Figure 29. North America Prostaglandin E2 Receptor EP4 Subtype Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. North America Prostaglandin E2 Receptor EP4 Subtype Revenue Share by Type (2021-2032) Figure 31. North America Prostaglandin E2 Receptor EP4 Subtype Revenue Share by Application (2021-2032) Figure 32. North America Prostaglandin E2 Receptor EP4 Subtype Revenue Share by Country (2021-2032) Figure 33. United States Prostaglandin E2 Receptor EP4 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. Canada Prostaglandin E2 Receptor EP4 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Mexico Prostaglandin E2 Receptor EP4 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Europe Prostaglandin E2 Receptor EP4 Subtype Revenue YoY Growth (2021-2032) & (US$ Million) Figure 37. Europe Prostaglandin E2 Receptor EP4 Subtype Revenue Share by Type (2021-2032) Figure 38. Europe Prostaglandin E2 Receptor EP4 Subtype Revenue Share by Application (2021-2032) Figure 39. Europe Prostaglandin E2 Receptor EP4 Subtype Revenue Share by Country (2021-2032) Figure 40. Germany Prostaglandin E2 Receptor EP4 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. France Prostaglandin E2 Receptor EP4 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. U.K. Prostaglandin E2 Receptor EP4 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Italy Prostaglandin E2 Receptor EP4 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Spain Prostaglandin E2 Receptor EP4 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Russia Prostaglandin E2 Receptor EP4 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. Netherlands Prostaglandin E2 Receptor EP4 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 47. Nordic Countries Prostaglandin E2 Receptor EP4 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. China Prostaglandin E2 Receptor EP4 Subtype Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. China Prostaglandin E2 Receptor EP4 Subtype Revenue Share by Type (2021-2032) Figure 50. China Prostaglandin E2 Receptor EP4 Subtype Revenue Share by Application (2021-2032) Figure 51. Asia Prostaglandin E2 Receptor EP4 Subtype Revenue YoY Growth (2021-2032) & (US$ Million) Figure 52. Asia Prostaglandin E2 Receptor EP4 Subtype Revenue Share by Type (2021-2032) Figure 53. Asia Prostaglandin E2 Receptor EP4 Subtype Revenue Share by Application (2021-2032) Figure 54. Asia Prostaglandin E2 Receptor EP4 Subtype Revenue Share by Region (2021-2032) Figure 55. Japan Prostaglandin E2 Receptor EP4 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. South Korea Prostaglandin E2 Receptor EP4 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. India Prostaglandin E2 Receptor EP4 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Australia Prostaglandin E2 Receptor EP4 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Taiwan Prostaglandin E2 Receptor EP4 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Southeast Asia Prostaglandin E2 Receptor EP4 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. SAMEA Prostaglandin E2 Receptor EP4 Subtype Revenue YoY Growth (2021-2032) & (US$ Million) Figure 62. SAMEA Prostaglandin E2 Receptor EP4 Subtype Revenue Share by Type (2021-2032) Figure 63. SAMEA Prostaglandin E2 Receptor EP4 Subtype Revenue Share by Application (2021-2032) Figure 64. SAMEA Prostaglandin E2 Receptor EP4 Subtype Revenue Share by Country (2021-2032) Figure 65. Brazil Prostaglandin E2 Receptor EP4 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Argentina Prostaglandin E2 Receptor EP4 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Chile Prostaglandin E2 Receptor EP4 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Colombia Prostaglandin E2 Receptor EP4 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Peru Prostaglandin E2 Receptor EP4 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Saudi Arabia Prostaglandin E2 Receptor EP4 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Israel Prostaglandin E2 Receptor EP4 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. UAE Prostaglandin E2 Receptor EP4 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Turkey Prostaglandin E2 Receptor EP4 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Iran Prostaglandin E2 Receptor EP4 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 75. Egypt Prostaglandin E2 Receptor EP4 Subtype Revenue YoY Growth (US$ Million) & (2021-2032) Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • ONO-4232
  • KAG-308
  • ER-886046
  • Grapiprant
  • E-7046
  • Others
Applications
  • Breast Cancer
  • Chronic Pain
  • Acute Pain
  • Allergies
  • Lung Cancer
  • Others
Companies covered
  • Eisai Co Ltd
  • Eli Lilly and Co
  • Rottapharm Biotech Srl
  • RaQualia Pharma Inc
  • Ono Pharmaceutical Co Ltd
  • Kaken Pharmaceutical Co Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Prostaglandin E2 Receptor EP4 Subtype Market by Type
  3. 1.2.1 Global Prostaglandin E2 Receptor EP4 Subtype Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 ONO-4232
  5. 1.2.3 KAG-308
  6. 1.2.4 ER-886046
  7. 1.2.5 Grapiprant
  8. 1.2.6 E-7046
  9. 1.2.7 Others
  10. 1.3 Prostaglandin E2 Receptor EP4 Subtype Market by Application
  11. 1.3.1 Global Prostaglandin E2 Receptor EP4 Subtype Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Breast Cancer
  13. 1.3.3 Chronic Pain
  14. 1.3.4 Acute Pain
  15. 1.3.5 Allergies
  16. 1.3.6 Lung Cancer
  17. 1.3.7 Others
  18. 1.4 Assumptions and Limitations
  19. 1.5 Study Goals and Objectives
2 Prostaglandin E2 Receptor EP4 Subtype Market Dynamics
  1. 2.1 Prostaglandin E2 Receptor EP4 Subtype Industry Trends
  2. 2.2 Prostaglandin E2 Receptor EP4 Subtype Industry Drivers
  3. 2.3 Prostaglandin E2 Receptor EP4 Subtype Industry Opportunities and Challenges
  4. 2.4 Prostaglandin E2 Receptor EP4 Subtype Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Prostaglandin E2 Receptor EP4 Subtype Market Perspective (2021-2032)
  2. 3.2 Global Prostaglandin E2 Receptor EP4 Subtype Growth Trends by Region
  3. 3.2.1 Global Prostaglandin E2 Receptor EP4 Subtype Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Prostaglandin E2 Receptor EP4 Subtype Market Size by Region (2021-2026)
  5. 3.2.3 Global Prostaglandin E2 Receptor EP4 Subtype Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Prostaglandin E2 Receptor EP4 Subtype Revenue by Players
  2. 4.1.1 Global Prostaglandin E2 Receptor EP4 Subtype Revenue by Players (2021-2026)
  3. 4.1.2 Global Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Prostaglandin E2 Receptor EP4 Subtype Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Prostaglandin E2 Receptor EP4 Subtype Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Prostaglandin E2 Receptor EP4 Subtype Key Players Headquarters & Area Served
  7. 4.4 Global Prostaglandin E2 Receptor EP4 Subtype Players, Product Type & Application
  8. 4.5 Global Prostaglandin E2 Receptor EP4 Subtype Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Prostaglandin E2 Receptor EP4 Subtype Market CR5 and HHI
  11. 4.6.3 2025 Prostaglandin E2 Receptor EP4 Subtype Tier 1, Tier 2, and Tier 3
5 Prostaglandin E2 Receptor EP4 Subtype Market Size by Type
  1. 5.1 Global Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2021-2032)
  3. 5.3 Global Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Type (2021-2032)
6 Prostaglandin E2 Receptor EP4 Subtype Market Size by Application
  1. 6.1 Global Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2021-2032)
  3. 6.3 Global Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Eisai Co Ltd
  2. 7.1.1 Eisai Co Ltd Company Information
  3. 7.1.2 Eisai Co Ltd Business Overview
  4. 7.1.3 Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Product Portfolio
  6. 7.1.5 Eisai Co Ltd Recent Developments
  7. 7.2 Eli Lilly and Co
  8. 7.2.1 Eli Lilly and Co Company Information
  9. 7.2.2 Eli Lilly and Co Business Overview
  10. 7.2.3 Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype Product Portfolio
  12. 7.2.5 Eli Lilly and Co Recent Developments
  13. 7.3 Rottapharm Biotech Srl
  14. 7.3.1 Rottapharm Biotech Srl Company Information
  15. 7.3.2 Rottapharm Biotech Srl Business Overview
  16. 7.3.3 Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype Product Portfolio
  18. 7.3.5 Rottapharm Biotech Srl Recent Developments
  19. 7.4 RaQualia Pharma Inc
  20. 7.4.1 RaQualia Pharma Inc Company Information
  21. 7.4.2 RaQualia Pharma Inc Business Overview
  22. 7.4.3 RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype Revenue and Gross Margin (2021-2026)
  23. 7.4.4 RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype Product Portfolio
  24. 7.4.5 RaQualia Pharma Inc Recent Developments
  25. 7.5 Ono Pharmaceutical Co Ltd
  26. 7.5.1 Ono Pharmaceutical Co Ltd Company Information
  27. 7.5.2 Ono Pharmaceutical Co Ltd Business Overview
  28. 7.5.3 Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Product Portfolio
  30. 7.5.5 Ono Pharmaceutical Co Ltd Recent Developments
  31. 7.6 Kaken Pharmaceutical Co Ltd
  32. 7.6.1 Kaken Pharmaceutical Co Ltd Company Information
  33. 7.6.2 Kaken Pharmaceutical Co Ltd Business Overview
  34. 7.6.3 Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Product Portfolio
  36. 7.6.5 Kaken Pharmaceutical Co Ltd Recent Developments
8 North America
  1. 8.1 North America Prostaglandin E2 Receptor EP4 Subtype Revenue (2021-2032)
  2. 8.2 North America Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2021-2032)
  3. 8.2.1 North America Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2021-2026)
  4. 8.2.2 North America Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2027-2032)
  5. 8.3 North America Prostaglandin E2 Receptor EP4 Subtype Revenue Share by Type (2021-2032)
  6. 8.4 North America Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2021-2032)
  7. 8.4.1 North America Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2021-2026)
  8. 8.4.2 North America Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2027-2032)
  9. 8.5 North America Prostaglandin E2 Receptor EP4 Subtype Revenue Share by Application (2021-2032)
  10. 8.6 North America Prostaglandin E2 Receptor EP4 Subtype Revenue by Country
  11. 8.6.1 North America Prostaglandin E2 Receptor EP4 Subtype Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Prostaglandin E2 Receptor EP4 Subtype Revenue by Country (2021-2026)
  13. 8.6.3 North America Prostaglandin E2 Receptor EP4 Subtype Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Prostaglandin E2 Receptor EP4 Subtype Revenue (2021-2032)
  2. 9.2 Europe Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2021-2032)
  3. 9.2.1 Europe Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2021-2026)
  4. 9.2.2 Europe Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2027-2032)
  5. 9.3 Europe Prostaglandin E2 Receptor EP4 Subtype Revenue Share by Type (2021-2032)
  6. 9.4 Europe Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2021-2032)
  7. 9.4.1 Europe Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2021-2026)
  8. 9.4.2 Europe Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2027-2032)
  9. 9.5 Europe Prostaglandin E2 Receptor EP4 Subtype Revenue Share by Application (2021-2032)
  10. 9.6 Europe Prostaglandin E2 Receptor EP4 Subtype Revenue by Country
  11. 9.6.1 Europe Prostaglandin E2 Receptor EP4 Subtype Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Prostaglandin E2 Receptor EP4 Subtype Revenue by Country (2021-2026)
  13. 9.6.3 Europe Prostaglandin E2 Receptor EP4 Subtype Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Prostaglandin E2 Receptor EP4 Subtype Revenue (2021-2032)
  2. 10.2 China Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2021-2032)
  3. 10.2.1 China Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2021-2026)
  4. 10.2.2 China Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2027-2032)
  5. 10.3 China Prostaglandin E2 Receptor EP4 Subtype Revenue Share by Type (2021-2032)
  6. 10.4 China Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2021-2032)
  7. 10.4.1 China Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2021-2026)
  8. 10.4.2 China Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2027-2032)
  9. 10.5 China Prostaglandin E2 Receptor EP4 Subtype Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Prostaglandin E2 Receptor EP4 Subtype Revenue (2021-2032)
  2. 11.2 Asia Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2021-2032)
  3. 11.2.1 Asia Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2021-2026)
  4. 11.2.2 Asia Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2027-2032)
  5. 11.3 Asia Prostaglandin E2 Receptor EP4 Subtype Revenue Share by Type (2021-2032)
  6. 11.4 Asia Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2021-2032)
  7. 11.4.1 Asia Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2021-2026)
  8. 11.4.2 Asia Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2027-2032)
  9. 11.5 Asia Prostaglandin E2 Receptor EP4 Subtype Revenue Share by Application (2021-2032)
  10. 11.6 Asia Prostaglandin E2 Receptor EP4 Subtype Revenue by Country
  11. 11.6.1 Asia Prostaglandin E2 Receptor EP4 Subtype Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Prostaglandin E2 Receptor EP4 Subtype Revenue by Country (2021-2026)
  13. 11.6.3 Asia Prostaglandin E2 Receptor EP4 Subtype Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Prostaglandin E2 Receptor EP4 Subtype Revenue (2021-2032)
  2. 12.2 SAMEA Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2027-2032)
  5. 12.3 SAMEA Prostaglandin E2 Receptor EP4 Subtype Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Prostaglandin E2 Receptor EP4 Subtype Revenue by Application (2027-2032)
  9. 12.5 SAMEA Prostaglandin E2 Receptor EP4 Subtype Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Prostaglandin E2 Receptor EP4 Subtype Revenue by Country
  11. 12.6.1 SAMEA Prostaglandin E2 Receptor EP4 Subtype Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Prostaglandin E2 Receptor EP4 Subtype Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Prostaglandin E2 Receptor EP4 Subtype Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst